Qi Quan, Li Rui, Li Hui-Ying, Cao Yu-Bing, Bai Ming, Fan Xiao-Jing, Wang Shu-Yan, Zhang Bo, Li Shao
Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
MOE Key Lab of Bioinformatics, Bioinformatics Division, TNLIST and Department of Automation, Tsinghua University, Beijing 100084, China.
Acta Pharmacol Sin. 2016 Jul;37(7):963-72. doi: 10.1038/aps.2016.53. Epub 2016 May 16.
Nuciferine is an aporphine alkaloid extracted from lotus leaves, which is a raw material in Chinese medicinal herb for weight loss. In this study we used a network pharmacology approach to identify the anti-tumor activity of nuciferine and the underlying mechanisms.
The pharmacological activities and mechanisms of nuciferine were identified through target profile prediction, clustering analysis and functional enrichment analysis using our traditional Chinese medicine (TCM) network pharmacology platform. The anti-tumor activity of nuciferine was validated by in vitro and in vivo experiments. The anti-tumor mechanisms of nuciferine were predicted through network target analysis and verified by in vitro experiments.
The nuciferine target profile was enriched with signaling pathways and biological functions, including "regulation of lipase activity", "response to nicotine" and "regulation of cell proliferation". Target profile clustering results suggested that nuciferine to exert anti-tumor effect. In experimental validation, nuciferine (0.8 mg/mL) markedly inhibited the viability of human neuroblastoma SY5Y cells and mouse colorectal cancer CT26 cells in vitro, and nuciferine (0.05 mg/mL) significantly suppressed the invasion of 6 cancer cell lines in vitro. Intraperitoneal injection of nuciferine (9.5 mg/mL, ip, 3 times a week for 3 weeks) significantly decreased the weight of SY5Y and CT26 tumor xenografts in nude mice. Network target analysis and experimental validation in SY5Y and CT26 cells showed that the anti-tumor effect of nuciferine was mediated through inhibiting the PI3K-AKT signaling pathway and IL-1 levels in SY5Y and CT26 cells.
By using a TCM network pharmacology method, nuciferine is identified as an anti-tumor agent against human neuroblastoma and mouse colorectal cancer in vitro and in vivo, through inhibiting the PI3K-AKT signaling pathways and IL-1 levels.
荷叶碱是从荷叶中提取的一种阿朴啡生物碱,是一种用于减肥的中草药原料。在本研究中,我们采用网络药理学方法来确定荷叶碱的抗肿瘤活性及其潜在机制。
通过使用我们的中药网络药理学平台进行靶点预测、聚类分析和功能富集分析,来确定荷叶碱的药理活性和机制。通过体外和体内实验验证荷叶碱的抗肿瘤活性。通过网络靶点分析预测荷叶碱的抗肿瘤机制,并通过体外实验进行验证。
荷叶碱的靶点谱富含信号通路和生物学功能,包括“脂肪酶活性调节”、“对尼古丁的反应”和“细胞增殖调节”。靶点谱聚类结果表明荷叶碱具有抗肿瘤作用。在实验验证中,荷叶碱(0.8 mg/mL)在体外显著抑制人神经母细胞瘤SY5Y细胞和小鼠结直肠癌CT26细胞的活力,荷叶碱(0.05 mg/mL)在体外显著抑制6种癌细胞系的侵袭。腹腔注射荷叶碱(9.5 mg/mL,腹腔注射,每周3次,共3周)显著降低裸鼠体内SY5Y和CT26肿瘤异种移植瘤的重量。在SY5Y和CT26细胞中的网络靶点分析和实验验证表明,荷叶碱的抗肿瘤作用是通过抑制SY5Y和CT26细胞中的PI3K-AKT信号通路和IL-1水平来介导的。
通过使用中药网络药理学方法,确定荷叶碱在体外和体内均为针对人神经母细胞瘤和小鼠结直肠癌的抗肿瘤药物,其作用机制是抑制PI3K-AKT信号通路和IL-1水平。